DMAA
Drugs Made In America Acquisition Corp. Rights
NASDAQ: DMAAR · ·
$0.09
-3.78% today
Updated 2026-04-29
Market cap
$1.73M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$—
Dividend yield
—
52W range
$0 – $0
Volume
0.2M
Drugs Made In America Acquisition Corp. Rights (DMAAR) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |